Sean E. Aeder

Array ( [id] => 5374132 [patent_doc_number] => 20090311693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'METHOD FOR THE IN VITRO SCREENING OF ANTI-CANCER COMPOUNDS THAT INHIBITS SK3 ACTIVITY, AND SAID ANTI-CANCER COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/376181 [patent_app_country] => US [patent_app_date] => 2007-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12720 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311693.pdf [firstpage_image] =>[orig_patent_app_number] => 12376181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5284860 [patent_doc_number] => 20090098535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'UPREGULATION OF RACK-1 IN MELANOMA AND ITS USE AS A MARKER' [patent_app_type] => utility [patent_app_number] => 11/831128 [patent_app_country] => US [patent_app_date] => 2007-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11537 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20090098535.pdf [firstpage_image] =>[orig_patent_app_number] => 11831128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4852481 [patent_doc_number] => 20080318224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'LARGE DELETIONS IN HUMAN BRCA1 GENE AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 11/830625 [patent_app_country] => US [patent_app_date] => 2007-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16920 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318224.pdf [firstpage_image] =>[orig_patent_app_number] => 11830625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4852480 [patent_doc_number] => 20080318223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'LARGE DELETIONS IN HUMAN BRCA1 GENE AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 11/830604 [patent_app_country] => US [patent_app_date] => 2007-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16918 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318223.pdf [firstpage_image] =>[orig_patent_app_number] => 11830604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4733857 [patent_doc_number] => 20080050836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'BIOMARKERS FOR SCREENING, PREDICTING, AND MONITORING BENIGN PROSTATE HYPERPLASIA' [patent_app_type] => utility [patent_app_number] => 11/829039 [patent_app_country] => US [patent_app_date] => 2007-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 28983 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20080050836.pdf [firstpage_image] =>[orig_patent_app_number] => 11829039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4745289 [patent_doc_number] => 20080089891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 11/880619 [patent_app_country] => US [patent_app_date] => 2007-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18656 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20080089891.pdf [firstpage_image] =>[orig_patent_app_number] => 11880619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4904460 [patent_doc_number] => 20080113874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'GEFITINIB SENSITIVITY-RELATED GENE EXPRESSION AND PRODUCTS AND METHODS RELATED THERETO' [patent_app_type] => utility [patent_app_number] => 11/781946 [patent_app_country] => US [patent_app_date] => 2007-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 28162 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113874.pdf [firstpage_image] =>[orig_patent_app_number] => 11781946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6627610 [patent_doc_number] => 20100004161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Toll Like Receptor 4 Dysfunction and the Biological Applications Thereof' [patent_app_type] => utility [patent_app_number] => 12/373789 [patent_app_country] => US [patent_app_date] => 2007-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 20886 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004161.pdf [firstpage_image] =>[orig_patent_app_number] => 12373789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4583600 [patent_doc_number] => 07851432 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-14 [patent_title] => 'Cytotoxic agents comprising new maytansinoids' [patent_app_type] => utility [patent_app_number] => 11/778437 [patent_app_country] => US [patent_app_date] => 2007-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 23 [patent_no_of_words] => 27470 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/851/07851432.pdf [firstpage_image] =>[orig_patent_app_number] => 11778437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8176237 [patent_doc_number] => 08178104 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-15 [patent_title] => 'Methods and compositions for targeting gC1qR/p32' [patent_app_type] => utility [patent_app_number] => 11/777382 [patent_app_country] => US [patent_app_date] => 2007-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 31 [patent_no_of_words] => 38029 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/178/08178104.pdf [firstpage_image] =>[orig_patent_app_number] => 11777382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8470038 [patent_doc_number] => 08299216 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-30 [patent_title] => 'Biomarkers for melanoma' [patent_app_type] => utility [patent_app_number] => 11/794832 [patent_app_country] => US [patent_app_date] => 2007-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 27530 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11794832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 43235 [patent_doc_number] => 07776555 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-08-17 [patent_title] => 'Colon disease targets and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/822094 [patent_app_country] => US [patent_app_date] => 2007-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40480 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/776/07776555.pdf [firstpage_image] =>[orig_patent_app_number] => 11822094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227171 [patent_doc_number] => 20120141376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'PROSTATE SPECIFIC TRANSCRIPTS AND THE USE THEREOF FOR PROSTATE CANCER THERAPEUTICS AND DIAGNOSTICS' [patent_app_type] => utility [patent_app_number] => 12/309478 [patent_app_country] => US [patent_app_date] => 2007-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25889 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12309478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10095383 [patent_doc_number] => 09131677 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-15 [patent_title] => 'Organ preservation solution' [patent_app_type] => utility [patent_app_number] => 12/306332 [patent_app_country] => US [patent_app_date] => 2007-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 5146 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12306332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422379 [patent_doc_number] => 20090148834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Methods of use of alpha-methylacyl-CoA racemase in hormone refractory and metastatic prostate cancers' [patent_app_type] => utility [patent_app_number] => 11/820705 [patent_app_country] => US [patent_app_date] => 2007-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 27275 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148834.pdf [firstpage_image] =>[orig_patent_app_number] => 11820705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4803002 [patent_doc_number] => 20080014590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer' [patent_app_type] => utility [patent_app_number] => 11/812518 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 54977 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20080014590.pdf [firstpage_image] =>[orig_patent_app_number] => 11812518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479623 [patent_doc_number] => 20090202580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'METHOD FOR THE PREPARATION OF SPECIFIC ANTIBODIES AGAINST SACCHARIDIC ANTIGENS' [patent_app_type] => utility [patent_app_number] => 12/308206 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6700 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202580.pdf [firstpage_image] =>[orig_patent_app_number] => 12308206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8908988 [patent_doc_number] => 08481047 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Malignant tumor-inhibiting preparation comprising Des A fibrin' [patent_app_type] => utility [patent_app_number] => 11/818783 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6296 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11818783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5165280 [patent_doc_number] => 20070286864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-13 [patent_title] => 'Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/811219 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17257 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20070286864.pdf [firstpage_image] =>[orig_patent_app_number] => 11811219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8911739 [patent_doc_number] => 08483815 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'EEG analysis system' [patent_app_type] => utility [patent_app_number] => 12/303736 [patent_app_country] => US [patent_app_date] => 2007-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 8335 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 228 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12303736 [rel_patent_id] =>[rel_patent_doc_number] =>)